Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heng Chi

Showing results (181-190 of 203) with videos related to

Pageof 21
Sort By:
Journal of Medicinal Chemistry|February 21, 2022
The Design and Optimization of Monomeric Multitarget Peptides for the Treatment of Multifactorial DiseasesTingkai Chen, Tianyu Sun, Yaoyao Bian, et al.
Molecular Cell|April 27, 2010
Diverse pathways generate microRNA-like RNAs and Dicer-independent small interfering RNAs in fungiHeng-Chi Lee, Liande Li, Weifeng Gu, et al.
Digestive Diseases and Sciences|August 31, 2013
Advanced disease, diuretic use, and marital status predict hospital admissions in an ambulatory cirrhosis cohortKara B Johnson, Emily J Campbell, Heng Chi, et al.
Alimentary Pharmacology & Therapeutics|January 29, 2019
Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis BKin Seng Liem, Margo J H van Campenhout, Qing Xie, et al.
Viruses|July 31, 2019
Caucasian Ethnicity, but Not Treatment Cessation is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg SeroconversionStijn Van Hees, Heng Chi, Bettina Hansen, et al.
Alimentary Pharmacology & Therapeutics|July 18, 2021
Serum hepatitis B virus RNA level is associated with biochemical relapse in patients with chronic hepatitis B infection who discontinue nucleos(t)ide analogue treatmentMuye Xia, Heng Chi, Yaobo Wu, et al.
Protein & Cell|July 20, 2016
Structural basis of Zika virus helicase in recognizing its substratesHongliang Tian, Xiaoyun Ji, Xiaoyun Yang, et al.
European Journal of Medicinal Chemistry|May 5, 2024
Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer's diseaseYing Chen, Weiting Zhang, Qi Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 3, 2017
Durability of Response After Hepatitis B Surface Antigen Seroclearance During Nucleos(t)ide Analogue Treatment in a Multiethnic Cohort of Chronic Hepatitis B Patients: Results After Treatment CessationHeng Chi, David Wong, Jie Peng, et al.
The Journal of Infectious Diseases|March 23, 2017
Pegylated Interferon Alfa-2b Add-on Treatment in Hepatitis B Virus Envelope Antigen-Positive Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogue: A Randomized, Controlled Trial (PEGON)Heng Chi, Bettina E Hansen, Simin Guo, et al.
Pageof 21

Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
Journal of Medicinal Chemistry|February 21, 2022
The Design and Optimization of Monomeric Multitarget Peptides for the Treatment of Multifactorial DiseasesTingkai Chen, Tianyu Sun, Yaoyao Bian, et al.
Molecular Cell|April 27, 2010
Diverse pathways generate microRNA-like RNAs and Dicer-independent small interfering RNAs in fungiHeng-Chi Lee, Liande Li, Weifeng Gu, et al.
Digestive Diseases and Sciences|August 31, 2013
Advanced disease, diuretic use, and marital status predict hospital admissions in an ambulatory cirrhosis cohortKara B Johnson, Emily J Campbell, Heng Chi, et al.
Alimentary Pharmacology & Therapeutics|January 29, 2019
Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis BKin Seng Liem, Margo J H van Campenhout, Qing Xie, et al.
Viruses|July 31, 2019
Caucasian Ethnicity, but Not Treatment Cessation is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg SeroconversionStijn Van Hees, Heng Chi, Bettina Hansen, et al.
Alimentary Pharmacology & Therapeutics|July 18, 2021
Serum hepatitis B virus RNA level is associated with biochemical relapse in patients with chronic hepatitis B infection who discontinue nucleos(t)ide analogue treatmentMuye Xia, Heng Chi, Yaobo Wu, et al.
Protein & Cell|July 20, 2016
Structural basis of Zika virus helicase in recognizing its substratesHongliang Tian, Xiaoyun Ji, Xiaoyun Yang, et al.
European Journal of Medicinal Chemistry|May 5, 2024
Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer's diseaseYing Chen, Weiting Zhang, Qi Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 3, 2017
Durability of Response After Hepatitis B Surface Antigen Seroclearance During Nucleos(t)ide Analogue Treatment in a Multiethnic Cohort of Chronic Hepatitis B Patients: Results After Treatment CessationHeng Chi, David Wong, Jie Peng, et al.
The Journal of Infectious Diseases|March 23, 2017
Pegylated Interferon Alfa-2b Add-on Treatment in Hepatitis B Virus Envelope Antigen-Positive Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogue: A Randomized, Controlled Trial (PEGON)Heng Chi, Bettina E Hansen, Simin Guo, et al.
Pageof 21